Prescriptions, Generics, and Discounts

Prescription drug coverage in the US is one of the most complex and variable elements of health insurance. Whether you are filling a prescription for a generic antibiotic or a specialty biologic, understanding how your plan’s formulary works, what generic medications offer, and what discount programs exist can meaningfully reduce your costs.

How health plan formularies work

A formulary is your health plan’s list of prescription drugs that it covers. Drugs on the formulary are organized into tiers, with different cost-sharing requirements at each tier. While tier structures vary by plan, a common arrangement looks like this:

• Tier 1: Preferred generics — lowest copay, typically just a few dollars per prescription.
• Tier 2: Non-preferred generics and some brand-name drugs — moderate copay.
• Tier 3: Preferred brand-name drugs — higher copay or coinsurance.
• Tier 4: Non-preferred brand-name and specialty drugs — highest cost-sharing, sometimes coinsurance rather than a flat copay.
• Specialty tier: High-cost biologics and specialty drugs — may require prior authorization and involve significant patient cost-sharing.

Not every drug is on every plan’s formulary. If your drug is not covered, you have options: ask your doctor about a formulary alternative (a drug in the same class that is covered), request a formulary exception from your insurer (requires your doctor to document medical necessity), or pay out of pocket at cash price — sometimes with a discount card at lower cost than your insurance tier copay.

Generic drugs: efficacy and savings

The US Food and Drug Administration (FDA) requires that generic drugs demonstrate bioequivalence to their brand-name counterparts. This means the generic must deliver the same active ingredient to the bloodstream at the same rate and extent as the original drug. Approval requires rigorous testing, not just a manufacturer’s claim.

Generics are substantially less expensive than brand-name drugs because the manufacturer does not have to recoup research and development costs — that investment was made by the original developer. Most major medications have generic versions available once the original patent protection expires. Requesting a generic when one is available is one of the most effective ways to reduce prescription costs.

Some brand-name medications have programs that allow patients to pay a discounted price — copay assistance cards from the manufacturer. These are typically available for brand-name drugs without a generic equivalent, subject to eligibility requirements (they often cannot be used by Medicare or Medicaid beneficiaries).

Medicare Part D: prescription coverage for Medicare enrollees

Medicare Part D provides prescription drug coverage to Medicare beneficiaries, either through standalone Part D plans (used with Original Medicare Parts A and B) or through Medicare Advantage plans that include drug coverage. Part D plans are offered by private insurers approved by Medicare and must cover a minimum set of drug categories — but they differ significantly in which specific drugs are covered and at what cost.

Key features of Part D:

• Each plan has its own formulary; enrollees should compare plans annually based on their specific medications.
• There is an annual deductible, then cost-sharing at each tier.
• The Medicare Part D program has a catastrophic coverage threshold — once annual out-of-pocket drug spending exceeds a defined amount set by CMS and adjusted annually, cost-sharing is reduced significantly. Rules have changed in recent years; check medicare.gov for current thresholds.
• Missing the initial Part D enrollment window results in a late enrollment penalty that adds to monthly premiums permanently, with exceptions for creditable drug coverage elsewhere.

The Extra Help program (also called the Low-Income Subsidy) provides premium, deductible, and copay assistance to Part D enrollees below defined income and asset thresholds. Applications are through the Social Security Administration.

Discount programs for uninsured and underinsured patients

Several categories of programs can reduce drug costs for people without insurance coverage or whose insurance does not cover a specific medication:

Manufacturer patient assistance programs (PAPs): Drug manufacturers often have programs that provide free or reduced-cost medications directly to low-income patients who are uninsured or underinsured. Eligibility criteria and application processes vary by company and drug.

Federally Qualified Health Centers (FQHCs): FQHCs participate in the 340B Drug Pricing Program, which allows them to purchase certain outpatient drugs at significantly reduced prices and pass savings to patients.

Pharmacy discount platforms: Third-party services and apps negotiate discounted cash prices at pharmacies for common generic drugs. These prices are sometimes lower than even insured copays. You pay directly and cannot use your insurance for the same transaction.

State programs: Many states have prescription assistance programs for specific populations (elderly, low-income, specific conditions). Contact your state health agency or check their website for available programs.

Comparing brand, generic, and biosimilar

Understanding the differences among brand-name drugs, generics, and biosimilars helps you ask informed questions when your provider prescribes a new medication.

Feature	Brand-name drug	Generic drug	Biosimilar
FDA approval pathway	Full NDA (New Drug Application)	Abbreviated NDA with bioequivalence data	BLA with biosimilarity data (no independent clinical trials required in most cases)
Active ingredient	Original formulation	Identical active ingredient	Highly similar biologic molecule
Inactive ingredients	Proprietary	May differ (generally minor clinical impact)	May differ
Typical cost	Highest	80–90% less than brand-name on average	Lower than reference biologic; gap varies
Interchangeability	N/A	Automatically substitutable in most states	“Interchangeable” designation required for automatic substitution
Patent status	Protected during exclusivity	Available after patent expiration	Available after reference biologic exclusivity expires
Examples	Humira (adalimumab), Ozempic (semaglutide)	Lisinopril, metformin, atorvastatin	Hadlima, Cyltezo (biosimilar adalimumabs)

If your plan places a brand-name drug on a high cost tier, always ask your provider whether a generic or biosimilar equivalent is clinically appropriate for your condition.

What this looks like in practice

Imagine you arrive in the US from Japan and require a medication for rheumatoid arthritis that you have been taking for two years. Your Japanese prescriber wrote you a summary. Your new US rheumatologist recognizes the medication — a biologic — and checks your insurer’s formulary.

The reference biologic is on the specialty tier with 30% coinsurance, potentially thousands of dollars per month. The formulary also includes a biosimilar of the same reference product at a lower specialty tier coinsurance. Your rheumatologist reviews the biosimilar’s FDA approval status, confirms it has been designated interchangeable with your medication, and discusses the substitution with you. You agree to try the biosimilar.

Separately, the rheumatologist prescribes a short course of prednisone as a bridge. Prednisone is a generic drug on Tier 1 — your copay is $5. For the biosimilar, your insurer requires prior authorization. Your rheumatologist’s office submits the PA with your prior treatment history. Authorization is granted in three business days, and your specialty pharmacy ships the medication directly to your home.

Step by step: finding the lowest cost for a prescription

1. Check the formulary before your appointment. If you know which medication you need, look it up in your plan’s formulary before the visit. See which tier it is on and what alternatives in the same class are at lower tiers.

2. Ask your provider about generic or biosimilar options. At the appointment, tell your provider you would like the most cost-effective option that is clinically appropriate. Many providers prescribe generics by default; for brand-name or biologic prescriptions, ask explicitly.

3. Check your copay at the pharmacy. When the prescription is submitted, ask the pharmacist for the cost under your insurance before paying. If the cost surprises you, move to the next step before accepting.

4. Compare a discount card price. Ask the pharmacist to look up a GoodRx or similar discount card price. These cards negotiate direct cash prices and sometimes beat even Tier 1 insurance copays, especially for common generics.

5. Ask about 90-day supply pricing. For chronic medications, a 90-day supply through mail-order or a preferred retail pharmacy is often cheaper per dose. Ask the pharmacist or call your insurer to set this up.

6. Check for manufacturer assistance. If you need a brand-name drug without a generic, search the manufacturer’s website for a copay savings card or patient assistance program. These are often not advertised at the pharmacy — you must apply directly.

7. Request prior authorization if denied. If your drug is not covered or is denied, ask your provider to submit a prior authorization or formulary exception request. Document the timeline and follow up within the insurer’s required review period.

Formulary exceptions and appeals: your rights when coverage is denied

When your insurer denies coverage for a medication or places it on a tier that makes it unaffordable, you have the right to appeal. The process includes:

Formulary exception request. If your medication is not on the formulary, your prescriber can submit a formulary exception request with clinical documentation explaining why the non-formulary drug is medically necessary for your specific condition and why formulary alternatives are not appropriate. Insurers are required to process urgent exception requests within 24 hours.

Tier exception request. If your drug is on the formulary but placed on a high-cost tier, you can request a tier exception — particularly if a lower-tier drug in the same class was tried and failed or is contraindicated. Tier exception decisions are typically made within 72 hours for standard requests.

Internal appeal. If an exception is denied, you can file an internal appeal with your insurer. Your insurer must notify you of the appeal timeline and decision.

External review. If your internal appeal fails, you have the right to an independent external review by an entity unaffiliated with your insurer. External reviewers consider both the clinical and plan-benefit evidence. Decisions are binding on the insurer in most states and under federal law for ACA-compliant plans.

Keeping records of all denial notices, appeal submissions, and response dates is essential to navigating this process effectively.

Medicare Part D drug cost protections: the $2,000 cap

The Inflation Reduction Act introduced a significant change to Medicare Part D that took effect in 2025: a $2,000 annual out-of-pocket cap on covered Part D drug spending. Before this change, there was no hard cap, and patients with high drug costs could face catastrophic spending. The cap means that once a Medicare Part D enrollee has paid $2,000 in out-of-pocket drug costs in a calendar year, their cost-sharing for covered drugs drops to $0 for the rest of the year.

Additionally, Medicare now has the authority to negotiate prices for certain high-cost drugs that lack generic or biosimilar competition — a new mechanism that did not exist before the Inflation Reduction Act. Negotiated prices apply to a growing list of drugs and reduce out-of-pocket costs for affected medications.

Medicare Part D enrollees with limited income and assets may also qualify for the Extra Help program (Low-Income Subsidy), which significantly reduces premiums, deductibles, and copays. Extra Help is administered by the Social Security Administration; eligibility is based on income and asset thresholds adjusted annually. Enrolling in Extra Help can reduce Part D out-of-pocket spending to a few dollars per prescription.

If you are assisting a Medicare-eligible family member with their prescription drug costs, reviewing their Part D plan annually during Open Enrollment (October 15 – December 7) is critical. Plan formularies and premiums change every year, and the lowest-cost plan for a given set of medications in one year may not be lowest in the next.

Documents and terms you will see

When navigating prescriptions and drug costs, you will encounter these terms in formularies, insurance letters, and pharmacy documents.

• Formulary — your plan’s list of covered drugs organized into cost tiers; your starting point for understanding drug coverage
• Formulary tier — the cost tier your drug is placed on; lower tiers mean lower copays or coinsurance
• Brand-name drug — a medication sold under a proprietary name by its originating manufacturer
• Generic drug — a bioequivalent copy of a brand-name drug available after patent expiration, at substantially lower cost
• Biosimilar — a highly similar version of a reference biologic medication; may be interchangeable depending on FDA designation
• Prior authorization — insurer approval required before certain medications are covered; initiated by your prescriber
• Step therapy — a coverage rule requiring you to try lower-cost medications first before coverage of a more expensive drug is approved
• Out-of-pocket maximum — the annual cap on your covered prescription and medical costs; once reached, the plan pays 100%